Sun Pharma’s arm to acquire 100% stake in Pola Pharma

26 Nov 2018 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma Global FZE -- has agreed to acquire 100% shares of Pola Pharma Inc., Japan, subject to completion of closing conditions, by way of cash consideration of 100 million Japanese Yen (around $1 million). This acquisition would give commercial presence in the dermatology segment in Japan.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1786.05 -40.05 (-2.19%)
10-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.05
Dr. Reddys Lab 1354.20
Cipla 1470.05
Lupin 2190.50
Zydus Lifesciences 1004.05
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.